RxDoctor Payments Data

David Newton, MD

Family Medicine · Port St Joe, FLNPI 1477991230

Payments from drug & device makers

$1,130in general payments, 2019–2025

Across 57 payments — averaging $19.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$340
  • Biosense Webster, Inc.$164
  • GSK$155
  • Lilly USA, LLC$121
  • Grifols USA, LLC$76
  • AstraZeneca$71
  • plus $202 from 6 others

What the payments were for

  • Travel & lodging$16415%
  • Food & beverage$96585%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,130 in reported general payments places this provider in the 65th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$2,477
Medicare patients
15
Services billed
25

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OctagamImmun Globg(Igg)/Malt/Iga Ov5022$460,106
OzempicSemaglutide57$99,475
EliquisApixaban81$88,933
MounjaroTirzepatide53$72,776
JardianceEmpagliflozin59$68,095
TrulicityDulaglutide21$31,873
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$30,248
JanuviaSitagliptin Phosphate12$14,775
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$12,879
Tresiba Flextouch U-100Insulin Degludec14$3,776
Atorvastatin Calcium338$3,205
Omeprazole119$2,657
Gabapentin74$2,393
Fluticasone-SalmeterolFluticasone Propion/Salmeterol11$2,307
Levothyroxine Sodium181$2,138

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerOctagam, Eliquis$21$549,039103 claims
Lilly USA, LLCMounjaro, Trulicity$121$104,64974 claims
Novo NordiskOzempic$340$99,47557 claims
GSKTrelegy Ellipta$155$30,24833 claims
AstraZenecaBreztri Aerosphere$71$12,87913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Port St Joe

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →